Oxford GlycoSciences Plc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford GlycoSciences Plc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (453)	4/13/2003 11:01:26 AM
From: scaram(o)uche	Read Replies (2) of 469

I hate the anti-heparanase project. Have from the second I heard about the deal. Sounds good until you look at all of the old projects that were designed to have the same biological effect, using small molecule inhibitors to block the interaction of growth factors with endothelial cells. Therefore, ol' Sir Chris might have his reason, but your thought probably put others off too. >> Sir Chris claims the 'gigantic lease liabilities' put him off bidding. << Well, the "cry wolf" tag is out of the bottle. Let's make sure it sticks for a gooooooooooood period. We've talked about the "2.35" ADR bail. I went back and checked my basis, and there was a sh*t load of shares sold at 2.30 as well. Another example, like Sibia and others, of a biotech investor getting "liquidity screwed" but making a pile in any event. Hope others did as well, but realize that that's probably not the case. Sucks. Wow, POWs rescued. Good to wake up to that. May the violence in Iraq end soon.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next